India Stock Market Daily Regulatory Digest — August 11, 2026

11-08-2026

Hero MotoCorp reported strong Q1 FY27 results with revenue of ₹12,999 Cr (+36% YoY) and PAT of ₹1,454 Cr, driven by 23% volume growth and an 8% mix benefit from premiumization, EVs, and scooters. While ICE volumes grew 21% and EV volumes surged 151%, the company noted a 67% industry-wide EV retail growth, indicating it is gaining share in a fast-growing but still small segment. The company also highlighted continued strong retail momentum in July (+28% YoY) and announced capacity expansions for EV (tripling to 45,000/month by year-end) and scooters.

• · Industry 2-wheeler retail grew 14% YoY in Q1 FY27, with ICE up 11% and EV up 67%.
• · Hero's wholesale market share increased by 30 bps in Q1.
• · ICE scooter market share gained 230 bps to ~7%.
• · EV market share gained >400 bps within 1 year.
• · Global business market share gained 110 bps within the quarter.
• · Parts and accessories business grew 30% YoY.
• · Splendor volume grew 15% YoY.
• · Flex fuel Splendor and HF sold ~5,000 units within 2 weeks of launch.
• · EV capacity tripling from 15,000/month to 45,000/month by end of FY27.
• · Additional Splendor capacity of 2,000/day added.
• · Destini capacity doubled.
• · Xoom capacity to be increased by 50%.
• · New CTO Sachin Agrawal joined in May 2026.
• · Anuj Dua appointed CBO for Premium segment, with focus on retail experience, portfolio expansion, merchandise/accessories, Harley-Davidson partnership, and MotoSports.

11-08-2026

Shanmuga Hospital Limited's Board approved unaudited financial results for Q1 FY27, an Employee Stock Option Plan (SHL ESOP-2026) for up to 3,50,000 options (2.58% of equity), a power purchase agreement with LNGS Private Limited at ₹6.10/unit, and an increase in authorized share capital from ₹14,00,00,000 to ₹25,00,00,000. The 6th Annual General Meeting is scheduled for September 18, 2026, with a record date of September 11, 2026. No financial performance figures or period-over-period comparisons were disclosed in this filing.

• · The Board approved alteration of the Main Object Clause of the Memorandum of Association to add two new clauses: providing support services to medical/educational institutions and dealing in software/digital solutions.
• · The Board approved alteration of the Articles of Association to update definitions, share capital provisions, and variation of rights of shareholders.
• · Book closure period for AGM: September 12, 2026 to September 18, 2026.
• · The Board meeting commenced at 03:00 PM and concluded at 05:50 PM.
• · The ESOP exercise price shall not be less than face value (₹10) and not more than the closing market price on the day prior to grant.
• · Options under ESOP vest between 1 to 3 years from grant date, with a 1-year exercise period post-vesting.

11-08-2026

Nephrocare Health Services Limited (NephroPlus) reported strong Q1FY27 results with revenue of ₹281.8 crore, up 23.7% YoY, and adjusted EBITDA of ₹65.1 crore, up 30.7% YoY. Adjusted PAT grew 41.7% YoY to ₹36.8 crore. However, adjusted PAT margin contracted slightly sequentially from 13.2% in Q4FY26 to 13.1% in Q1FY27, and the company's adjusted EBITDA margin improved 120 bps YoY but also improved 220 bps sequentially, indicating mixed margin trends.

• · The company operates 550 clinics across 5 countries (India, Nepal, Philippines, Uzbekistan, Saudi Arabia).
• · A significant milestone of 50 clinics in the Philippines was achieved.
• · NephroPlus International Dialysis Academy (NIDA) was launched to train renal nurses.
• · NephroPlus Dialysis Index, a composite health score, was launched to monitor clinical outcomes.
• · Management commentary highlights shift from unorganized to organized dialysis market in India, with only 21% currently served by pure-play networks.
• · Company is exploring entry into new countries via strategic acquisitions or long-term partnerships.
• · Adjusted PAT margin contracted slightly sequentially from 13.2% in Q4FY26 to 13.1% in Q1FY27.

11-08-2026

360 ONE WAM LIMITED has issued the Notice for its 19th Annual General Meeting (AGM) to be held on September 2, 2026, via video conferencing, along with the Annual Report for FY2025-26. The agenda includes adoption of audited standalone and consolidated financial statements, re-appointment of directors Yatin Shah and Pavninder Singh by rotation, and approval of a new Employee Stock Appreciation Rights (ESAR) Scheme 2026 for up to 11,20,000 equity shares. The filing is a routine procedural disclosure with no financial performance data or period-over-period comparisons provided.

• · The 19th AGM will be held on Wednesday, September 2, 2026, at 12:00 noon IST through Video Conferencing / Other Audio Visual Means.
• · The deemed venue is the registered office at 360 ONE Centre, Kamala City, Senapati Bapat Marg, Lower Parel, Mumbai, Maharashtra, 400013.
• · The Notice and Annual Report are sent electronically to shareholders with registered email IDs; a letter with web-link and QR Code is sent to those without registered email IDs.
• · Agenda includes two special resolutions: formation of the ESAR Scheme 2026 for employees of the Company and its extension to employees of wholly owned subsidiaries.
• · The ESAR Scheme 2026 is capped at 11,20,000 fully paid-up equity shares of face value Re. 1 each.
• · No financial results, revenue, profit, or period-over-period comparisons are disclosed in this filing.

11-08-2026

C.E. Info Systems Limited held its 31st Annual General Meeting on August 11, 2026, where all five resolutions were passed with overwhelming majority. Resolutions included adoption of financial statements, dividend declaration, re-appointment of a director, approval of a material related party transaction with subsidiary Gtropy Systems Private Limited, and appointment of Mr. Rohan Verma as Joint Managing Director. While all resolutions passed with over 99% approval from votes polled, the appointment of Mr. Rohan Verma saw notable dissent from public institutional shareholders, with 2.25% voting against.

• · The AGM was conducted through Video Conferencing (VC) and Other Audio Visual Means (OAVM).
• · Remote e-voting period ran from August 8, 2026 at 9:00 AM to August 10, 2026 at 5:00 PM IST.
• · The cut-off date for entitlement to vote was August 4, 2026.
• · For Resolution 4 (related party transaction with Gtropy Systems), promoters abstained from voting as per SEBI regulations, and their holding of 28,150,637 equity shares were considered invalid.
• · One shareholder holding 588 equity shares abstained from voting on Resolution 1.
• · The scrutinizer's report was countersigned by the Chairman.

11-08-2026

Inox Green Energy Services Limited submitted a Monitoring Agency Report from CARE Ratings for the quarter ended June 30, 2026, confirming no deviation from the objects of its Rs. 1050.00 crore preferential issue. However, the company received only Rs. 966.30 crore of the issue proceeds due to the cancellation of ~77 lakh warrants on January 28, 2026, following non-exercise of conversion options, leading to a downward revision in the total cost and allocations for debt repayment, investment in subsidiaries, and general corporate purposes.

• · The monitoring agency report covers the quarter ended June 30, 2026.
• · The issue period was July 25, 2024 to August 7, 2024.
• · The type of specified securities issued were Equity Shares and Convertible Warrants.
• · The unutilized proceeds are parked in deposits with scheduled commercial banks and as balance in monitoring account.
• · Shareholder approval was obtained for the revision in total cost from Rs. 1050 crore to Rs. 966.30 crore.
• · The reallocation of funds was approved by the 'IGESL Committee of Board of Directors for Operations'.
• · The revised allocation for General Corporate Purposes (Rs. 235.66 crore) does not exceed 25% of the proceeds of the preferential issue.
• · No major deviation was observed over earlier monitoring agency reports.
• · No favorable/unfavorable events affecting viability of objects were noted.

11-08-2026

Balrampur Chini Mills Limited submitted the Monitoring Agency Report from India Ratings & Research for the quarter ended June 30, 2026, confirming no deviation from the objects of its ₹450 Crore preferential issue. The company has utilized ₹170.74 Crore of the proceeds, with ₹60.74 Crore spent on the Poly Lactic Acid (PLA) project and ₹110 Crore on general corporate purposes (repayment of working capital demand loan). However, ₹279.26 Crore remains unutilized, and the Gypsum Processing Plant has seen no progress, with the entire ₹110 Crore allocated to it still idle.

• · The preferential issue was made at ₹483 per share (face value ₹1 each) during the period 20th May 2026 to 3rd June 2026.
• · The PLA project has a completion deadline of on or before 31st December 2026 and is ongoing.
• · The Gypsum Processing Plant has a completion deadline of on or before 31st December 2027 and is ongoing, but no funds have been utilized yet.
• · Unutilized proceeds of ₹279.26 Crore are deployed in fixed deposits with Axis Bank and PNB Bank (earning 7.20%-7.30% p.a.) and in SBI Overnight Fund (market value ₹19.36 Crore).
• · The monitoring bank account (HDFC) had a negligible balance of ₹392 only.

11-08-2026

Manaksia Aluminium Company Limited reported a 3.8% YoY increase in revenue from operations to ₹13,958.97 Lakh for Q1 FY27, while net profit surged 83.0% YoY to ₹285.06 Lakh. However, sequentially revenue declined 10.3% from ₹15,565.68 Lakh in Q4 FY26, and net profit fell 11.9% from ₹323.52 Lakh. The Board proposed a final dividend of Re. 0.05 per share (5% on face value of Re. 1) for FY26 and approved the re-appointment of Mr. Sunil Kumar Agrawal as Managing Director for three more years. The company faces a GST demand of ₹38.80 Crore plus penalty, which management is contesting.

• · The Board approved re-appointment of Mr. Sunil Kumar Agrawal as Managing Director for 3 years w.e.f. 23rd November 2026, subject to shareholder approval.
• · Record date for dividend and e-voting is 15th September 2026.
• · The company incorporated two subsidiaries: Manaksia Aluminium Inc. (USA) on 30 Aug 2024 and Metal Star Celling Panel FZE (UAE) on 11 Jul 2025, but share application money not yet deposited, so no consolidated results.
• · GST demand of ₹38.80 Crore plus ₹3.88 Crore penalty is being contested; management believes no liability needs recognition.
• · Basic EPS for Q1 FY27 stood at ₹0.43 (vs ₹0.24 in Q1 FY26 and ₹0.49 in Q4 FY26).
• · Finance cost increased 3.3% YoY to ₹728.99 Lakh (from ₹705.95 Lakh).
• · Employee benefits expense rose 3.0% YoY to ₹435.79 Lakh.
• · Other expenses increased 14.9% YoY to ₹2,562.62 Lakh.

11-08-2026

TARC Limited's Board approved Q1 FY27 consolidated results showing revenue from operations of ₹21,712.59 Lakh, up 187% YoY from ₹7,549.48 Lakh, but net profit after tax fell 58% YoY to ₹2,264.57 Lakh from ₹5,421.41 Lakh, impacted by a sharp decline in other income. The Board also approved the acquisition of the remaining 50% stake in Niblic Greens Hospitality Private Limited for ₹55 Lakh, making it a wholly owned subsidiary, and recommended the appointment of M/s Singhi & Co. as statutory auditor and the continuation of Mr. Anil Sarin as director beyond age 75.

• · The Board approved amendments to the redemption schedule of NCDs (ISIN INE0EK907050), with the final maturity amount revised from ₹442,24,48,000 to ₹444,71,21,112 on March 31, 2030.
• · The 10th Annual General Meeting is scheduled for September 19, 2026 at 11:00 AM IST via video conferencing.
• · The Board noted the completion of tenure of M/s Doogar & Associates as statutory auditor at the conclusion of the 10th AGM.
• · The consolidated results include 26 subsidiaries/step subsidiaries/LLPs with total revenue of ₹8.00 Lakh and net loss of ₹14.29 Lakh for the quarter.
• · The group operates in a single business segment: real estate.
• · The Debt Service Coverage Ratio improved to 0.49 from 0.12 in the prior year quarter.
• · The Interest Service Coverage Ratio declined to 2.36 from 6.49 in the prior year quarter.

11-08-2026

Laxmi Dental Limited's Board approved the allotment of 59,360 equity shares under ESOP 2024, increasing paid-up capital to 5,50,21,509 shares, and noted the execution of a Letter of Intent for land acquisition in Palghar, Maharashtra for INR 6,21,00,000 (₹6.21 Cr) to build a factory. The company also reported unaudited Q1 FY26-27 financial results, which were reviewed by the statutory auditor with no material misstatements noted. However, the filing does not include the actual financial figures, so performance trends cannot be assessed from this document.

• · The land acquisition is for expansion of business operations by construction of a factory.
• · The seller, Mr. Jigar Ramesh Bafna, is not related to the promoter/promoter group.
• · The transaction is not a related party transaction.
• · The ESOP allotment was at an exercise price of INR 2 per share.
• · The surrendered ESOPs will be cancelled and added back to the pool for future grants.
• · The auditor's review report covers consolidated results including subsidiaries and joint ventures; five subsidiaries were reviewed by other auditors, and one joint venture's financials were not reviewed by an auditor but were deemed immaterial.
• · The auditor's conclusion was unmodified (no material misstatements found).

11-08-2026

Kerala Financial Corporation (KFC) reported unaudited financial results for Q1 FY27 (quarter ended June 30, 2026). Net profit after tax declined 37.2% YoY to ₹3,550.71 Lakh from ₹5,654.32 Lakh in Q1 FY26, while total revenue remained nearly flat at ₹24,184.00 Lakh (down 0.25% YoY). Asset quality deteriorated significantly, with Gross NPA rising to 3.44% from 2.32% as of March 31, 2026, and Net NPA increasing to 1.25% from 0.43%.

• · Interest expenses rose 11.8% YoY to ₹18,239.96 Lakh, outpacing the 1.6% growth in net interest income.
• · Other income declined 21.1% YoY to ₹1,679.97 Lakh.
• · Loan processing fees dropped 54.3% YoY to ₹116.80 Lakh.
• · Recovery from written-off loans increased 19.2% YoY to ₹1,790.37 Lakh.
• · The Corporation availed ₹2,07,435.46 Lakh in foreign currency loans from SBI (tenor ≤180 days, fully hedged).
• · Total portfolio stood at ₹8,21,880.22 Lakh as of June 30, 2026.
• · Debt-Equity ratio stood at 5.52 times.
• · CRAR was 32.87%.
• · No additional provision for bad debts was made in Q1 FY27 as existing provisions of ₹22,453.53 Lakh exceeded the minimum requirement of ₹8,877.86 Lakh.
• · Cash and cash equivalents decreased to ₹14,369.52 Lakh from ₹19,973.61 Lakh as of March 31, 2026.

11-08-2026

Aries Agro Limited's Board approved unaudited standalone and consolidated financial results for Q1 FY27 (ended June 30, 2026). On a consolidated basis, net profit rose 49.5% YoY to ₹1,484.54 Lakhs, while net income from operations grew 16.3% YoY to ₹18,585.77 Lakhs. However, the company reported a net loss of ₹478.78 Lakhs in the preceding quarter (Q4 FY26), highlighting sequential volatility. The Board also approved the re-appointment of Dr. Rahul Mirchandani as Managing Director for five years from April 1, 2027, and Mr. Nrupang Bhumitra Dholakia as Independent Director for a second term from March 15, 2027 to March 14, 2032, both subject to shareholder approval.

• · The Board fixed September 22, 2026 as the record date for determining entitlement to the Dividend-2025-26, with payment on or before October 23, 2026.
• · The Annual General Meeting is scheduled for September 29, 2026.
• · The company has 3 subsidiaries (2 wholly owned: Mirabelle Agro Manufacturing Pvt. Ltd. and Aries Agro Equipments Pvt. Ltd.; 1 subsidiary: Golden Harvest Middle East, FZC) and 1 associate (Amarak Chemicals, FZC).
• · The business is seasonal due to cropping patterns and weather conditions, so quarterly figures are not representative of full-year performance.
• · Statutory auditors Kirti D. Shah & Associates issued a limited review report on the standalone financial results.

11-08-2026

DAM Capital Advisors Limited's Board approved unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended June 30, 2026). The company appointed Mr. Dhvanil Sanjiv Dharia as Additional Director and Whole Time Director for five years, while Independent Director Mr. Natarajan Srinivasan will complete his tenure on August 18, 2026. The 33rd Annual General Meeting is scheduled for September 8, 2026.

• · Mr. Dhvanil Sanjiv Dharia, aged 35, holds a B.Tech from ICT and an MBA from London Business School, and is a CFA charter holder.
• · Mr. Dharia has been with DAM Capital since its inception in 2019 and leads the Investment Banking division covering ECM, Private Equity, and advisory.
• · The Board meeting commenced at 3:48 PM IST and concluded at 5:09 PM IST on August 11, 2026.
• · The unaudited financial results were reviewed by the auditor KKC & Associates LLP, who issued an unmodified conclusion.
• · One subsidiary (DAM Asset Management Limited) had nil revenue and negligible loss for the quarter; its financials were not reviewed by an auditor.
• · IDFC Securities Singapore Pte. Ltd was dissolved and liquidated effective November 16, 2021; an application for cancellation of its Unique Document Identification Number has been filed with RBI.

11-08-2026

EPACK Durable Limited reported consolidated revenue of ₹88,602.35 lakh for Q1 FY27 (quarter ended June 30, 2026), up 33.8% YoY from ₹66,239.25 lakh in Q1 FY26. However, net profit fell 48.4% YoY to ₹1,181.79 lakh from ₹2,289.13 lakh, and the auditor issued a qualified opinion due to a disputed trade receivable of ₹1,961 lakh. The company also reversed ₹3,242 lakh in PLI income in the prior quarter after failing to meet incremental sales thresholds.

• · Auditor issued a qualified opinion due to disputed trade receivable of ₹1,961 lakh from one customer; legal recovery actions are ongoing.
• · PLI income of ₹3,242 lakh accrued in 9M FY26 was fully reversed in Q4 FY26 after failing to meet incremental sales thresholds for FY26.
• · RIPS 2024 incentive income of ₹183.67 lakh recognized in Q1 FY27; ₹2,177.36 lakh recognized in Q4 FY26.
• · Share of loss from joint venture (Epavo Electricals) was ₹229.18 lakh in Q1 FY27 vs ₹28.74 lakh in Q1 FY26.
• · Total expenses grew 36.4% YoY to ₹86,783.21 lakh, outpacing revenue growth.
• · Finance costs increased 27.6% YoY to ₹2,021.91 lakh.
• · Board re-appointed M/s Ernst & Young LLP as Internal Auditor for FY27.

11-08-2026

Landmarc Leisure Corporation Ltd. reported a net profit of ₹4.67 Lakh for the quarter ended June 30, 2026, compared to a net loss of ₹18.81 Lakh in the same quarter last year, driven primarily by improvement in its Motion Pictures business segment, which generated revenue of ₹26.24 Lakh versus ₹0.88 Lakh a year ago. However, the company's auditors issued a modified opinion, and the Packaged Water Bottle segment recorded no revenue. The company is also addressing significant past advances/deposits to two parties that have entered resolution under the Insolvency and Bankruptcy Code, totaling ₹6376.71 Lakh and ₹1500 Lakh respectively.

• · Statutory auditors issued a modified opinion on the Q2 FY26 financial results.
• · The company has not carried out actuarial valuation as per Ind AS 19 for gratuity; provision made on ad-hoc basis.
• · The company has not recognised interest income on deposits to SKM Real Infra Ltd (₹2,218.28 Lakh) or Shree Ram Urban Infrastructure Ltd (₹1500 Lakh), both under IBC resolution.
• · Potential equity shares are antidilutive, so diluted EPS equals basic EPS (₹37.79 for Q2 FY26).
• · Segment-wise total assets: ₹4,920.50 Lakh (up from ₹4,217.66 Lakh a year ago); total liabilities: ₹470.89 Lakh (down from ₹1,754.72 Lakh a year ago).
• · Paid-up equity capital increased from ₹8,000.00 Lakh to ₹9,800.00 Lakh during the year (preferential issue completed).
• · The company will hold its 35th AGM on 24 September 2026 via video conferencing; cut-off date for e-voting is 17 September 2026.

11-08-2026

Sayaji Hotels (Pune) Limited has issued notice for its 8th Annual General Meeting (AGM) to be held on September 4, 2026, via video conferencing. The AGM will consider the adoption of audited standalone and consolidated financial statements for FY2025-26, the re-appointment of Whole-Time Director Mr. Zuber Yusuf Dhanani, and the appointment of Mrs. Isha Garg as a Non-Executive Independent Director for a five-year term. The filing is a routine corporate governance disclosure with no financial results or performance data provided.

• · The AGM will be held on Friday, September 4, 2026 at 3:00 PM IST through Video Conferencing / Other Audio-Visual Means.
• · Deemed venue of the AGM is the Registered Office at Near Kala Ghoda Circle, Sayajiganj, Vadodara, Gujarat-390020.
• · Mr. Zuber Yusuf Dhanani retires by rotation and offers himself for re-appointment as Whole-Time Director.
• · Mrs. Isha Garg is proposed to be appointed as Independent Director for a term of 5 years from August 6, 2026 to August 5, 2031, subject to member approval by Special Resolution.
• · Remote e-voting facility is provided through CDSL; proxy appointment is not available for this AGM.
• · Members holding shares in physical form are required to furnish PAN, KYC details, and nomination to avoid freezing of folios.

11-08-2026

Allcargo Terminals Limited reported a strong Q1 FY27 with standalone profit after tax surging 183% YoY to ₹13.50 Cr, driven by a 13% increase in income from operations to ₹146.93 Cr and a sharp rise in other income (₹9.21 Cr vs ₹2.26 Cr YoY) largely from a ₹7.74 Cr dividend from its joint venture. However, the company faces significant regulatory headwinds: an income tax demand of ₹49.35 Cr for a block period (appealed) and a GST demand of ₹25.29 Cr plus penalty (interim stay granted). The Board also approved the appointment of Mr. Pranav Choudhary as Managing Director effective September 1, 2026, and extended an inter-corporate deposit of ₹30 crore from its subsidiary for one more year.

• · Standalone basic EPS for Q1 FY27: ₹0.51 (vs ₹0.18 in Q1 FY26); diluted EPS: ₹0.48 (vs ₹0.18).
• · Total comprehensive income for Q1 FY27: ₹13.37 Cr (vs ₹4.70 Cr in Q1 FY26).
• · Paid-up equity share capital as of Jun 30, 2026: ₹52.40 Cr (face value ₹2 each).
• · Other equity as of Mar 31, 2026: ₹304.48 Cr.
• · The company received an income tax assessment order on May 6, 2026 demanding ₹49.35 Cr; ₹0.22 Cr provisioned, balance appealed.
• · A GST demand of ₹25.29 Cr plus equal penalty is under interim stay from Madras High Court.
• · Board extended the tenure of an inter-corporate deposit of ₹30 Cr from subsidiary Speedy Multimodes Ltd for one more year (Sep 2026 to Sep 2027).
• · Board reconstituted committees effective Sep 1, 2026.

11-08-2026

Bodhtree Consulting Limited's board approved a name change to 'Datakosa Limited' and a preferential issue of 23,52,940 equity shares at ₹17 per share (including ₹7 premium) to two non-promoter investors, Nerdix Technologies LLP and Virello Estates LLP, for total consideration of approximately ₹4.00 Cr. The board also approved alteration of the objects clause, the annual report for FY 2025-26, and set the 44th AGM for September 9, 2026. No financial results or period-over-period comparisons were disclosed in this filing.

• · The board approved alteration of the Objects Clause (Clause III (A)) of the Memorandum of Association, subject to members’ approval.
• · The board approved the Board’s Report along with annexures for FY 2025-26, forming part of the 44th Annual Report.
• · The 44th AGM will be held on Wednesday, September 09, 2026, at 11:00 a.m. IST via Video Conferencing.
• · Record date for AGM eligibility is Thursday, September 03, 2026; remote e-voting runs from September 06 to September 08, 2026.
• · Mr. Y. Ravi Prasada Reddy was appointed as Scrutinizer for the e-voting and AGM voting process.
• · The name change does not alter the legal status, constitution, or rights/obligations of the company or its stakeholders.
• · The preferential issue does not trigger an open offer under SEBI (SAST) Regulations, 2011.

11-08-2026

Calcom Vision Ltd. reported a 33.9% YoY increase in standalone revenue from operations to ₹6,033.32 Lakh for the quarter ended June 30, 2026, while consolidated revenue rose 33.3% to ₹6,007.99 Lakh. However, standalone profit after tax declined 33.8% YoY to ₹46.28 Lakh, and consolidated profit attributable to owners plunged 78.9% to ₹13.22 Lakh, dragged by losses from its joint venture and subsidiary. The company also secured eligibility for the PLI scheme for White Goods under a higher investment category of ₹25.00 Crore.

• · Standalone total expenses rose 35.0% YoY to ₹5,986.13 Lakh, outpacing revenue growth.
• · Consolidated profit before tax declined 51.8% YoY to ₹45.28 Lakh.
• · The subsidiary Calcom Astra Private Limited reported a net loss of ₹8.63 Lakh on revenue of ₹13.02 Lakh for the quarter.
• · The joint venture Calcom Taehwa Techno Private Limited contributed a loss of ₹19.20 Lakh to the group's share.
• · The company's wholly-owned non-operational subsidiary Calcom Kadappa Pvt. Ltd. was struck off by the MCA effective December 2, 2025, making prior-period consolidated figures not strictly comparable.
• · Paid-up equity share capital stood at ₹1,398.53 Lakh (face value ₹10 each).
• · Standalone reserves (excluding revaluation reserve) were ₹4,610.58 Lakh as of March 31, 2026.
• · The company is evaluating the new Labour Codes but has not yet quantified the impact.

11-08-2026

Delton Cables Ltd. reported unaudited financial results for Q1 FY27 (quarter ended June 30, 2026), with revenue from operations surging 83.2% YoY to ₹28,636.20 Lakh (₹286.36 Cr) from ₹15,633.18 Lakh in Q1 FY26. Net profit jumped 146.3% YoY to ₹759.13 Lakh (₹7.59 Cr) from ₹308.27 Lakh. However, sequentially (vs Q4 FY26), revenue declined 10.6% from ₹32,030.98 Lakh, and net profit fell 83.8% from ₹1,052.17 Lakh (excluding exceptional items), indicating a sharp quarter-on-quarter slowdown.

• · Board approved un-audited financial results for quarter ended June 30, 2026 with limited review report.
• · 61st Annual General Meeting scheduled for September 29, 2026 at 12:00 Noon via VC/OAVM.
• · Register of Members & Share Transfer Books closure from September 23, 2026 to September 29, 2026 for final dividend eligibility.
• · Record date for final dividend entitlement fixed as September 22, 2026.
• · Dividend, if declared, will be paid within 30 days from declaration.
• · Auditors (Bansal & Co LLP) issued an unmodified (clean) review opinion on the financial results.
• · Company operates as a single operating segment per Ind AS 108.
• · Total comprehensive income for Q1 FY27 was ₹759.13 Lakh (no OCI items in current quarter vs ₹21,002.66 Lakh in Q4 FY26 which included a large revaluation gain).
• · Finance costs increased 67.5% YoY to ₹1,294.01 Lakh from ₹772.82 Lakh.
• · Cost of materials consumed rose 40.0% YoY to ₹20,739.50 Lakh from ₹14,818.08 Lakh.

11-08-2026

Bosch Limited held its 74th Annual General Meeting (AGM) on August 11, 2026, where shareholders approved all eight resolutions, including the adoption of standalone and consolidated financial statements for FY ended March 31, 2026, a final dividend of ₹270 per equity share, reappointment of Stefan Grosch, ratification of cost auditor remuneration, material related party transactions with Robert Bosch GmbH and Bosch Automotive Electronics India Private Limited, and the appointment of Ramesh Ramadurai as a Non-Executive Independent Director. The meeting was chaired by Soumitra Bhattacharya and saw participation from key directors and auditors. No financial performance metrics, comparative data, or additional operational updates were disclosed in the filing.

• · Dividend of ₹270 per share declared, subject to shareholder approval via voting.
• · Meeting was held at Trinity Hall, Taj MG Road, Bengaluru, starting at 11:00 a.m. and concluding at 1:45 p.m. (IST).
• · Remote e-voting period: August 7, 2026 (9:00 a.m.) to August 10, 2026 (5:00 p.m.).
• · Scrutinizer appointed: Prasanna Bedi, Practicing Company Secretary.
• · Appointment of Ramesh Ramadurai as Non-Executive Independent Director for 5 years required a special resolution.

11-08-2026

Trigyn Technologies reported consolidated revenue from operations of ₹25,275.74 lakhs for Q1 FY27, up 12.6% YoY from ₹22,449.99 lakhs in Q1 FY26. Consolidated net profit turned around to ₹348.75 lakhs from a loss of ₹460.87 lakhs in the same quarter last year. However, standalone performance was weak, with a net loss of ₹247.98 lakhs versus a loss of ₹499.02 lakhs YoY, and the company faces significant legal, tax, and collection uncertainties, including a GST demand of ₹9.08 crore and an income tax demand of ₹3.14 crore.

• · Consolidated total comprehensive income for Q1 FY27 was ₹2,807.59 lakhs, up from a loss of ₹403.50 lakhs in Q1 FY26.
• · Standalone total comprehensive income for Q1 FY27 was ₹965.59 lakhs, compared to a loss of ₹531.15 lakhs in Q1 FY26.
• · The company has not booked ₹80 crore of Quarterly Guaranteed Revenue from the APSFL project due to collection uncertainty.
• · Outstanding from APSFL project of ₹61.50 crore is more than 7 years old; full ECL provision of ₹61.50 crore has been made.
• · GST demand of ₹9.08 crore for FY 2019-20 to FY 2022-23 has been appealed.
• · Income tax demand of ₹3.14 crore for block assessment period 2014-15 to 2019-20 is under appeal.
• · Unamortized capital cost for the Nashik parking project stands at ₹3.30 crore; termination notice received and arbitration ongoing.
• · Two subsidiaries (Leading Edge Infotech and Trigyn Technologies India Pvt Ltd) have negative net worth and depend on holding company support.
• · The company has received principal amounts of ₹500 lakhs from United Telecoms Limited and ₹200 lakhs from Priyaraja Electronics Limited on 10th August 2026.
• · Investment in IIRM Holdings Limited shows unrealized gain of ₹1,619.15 lakhs recognized in OCI.
• · Working capital facilities of ₹100 crore are secured by immovable property, collateral, personal guarantee of promoter director, and corporate guarantees.

11-08-2026

P.H. Capital Ltd. (now proposed to be renamed AHB Capital Ltd.) reported a sharp decline in net profit for the quarter ended June 30, 2026, with profit falling to ₹29.01 Lakh from ₹700.13 Lakh in the same quarter last year, a drop of approximately 96%. Revenue from operations also fell significantly to ₹8.49 Lakh from ₹5,759.63 Lakh. However, the board approved a massive 10:1 bonus issue and an increase in authorized share capital from ₹4,00,00,000 to ₹44,00,10,000, signaling a strategic restructuring under new management.

• · The company reported a net loss of ₹39.49 Lakh in total comprehensive income for Q1 FY27, compared to a gain of ₹700.13 Lakh in Q1 FY26.
• · Other income rose to ₹526.70 Lakh in Q1 FY27 from nil in Q1 FY26, partially offsetting the revenue collapse.
• · The board approved a 10:1 bonus issue, capitalising up to ₹30,00,10,000 from free reserves.
• · Authorised share capital is proposed to increase from ₹4,00,00,000 to ₹44,00,10,000.
• · The company plans to explore raising up to ₹200 crore through various instruments.
• · New management team appointed: Aditya Himmat Bhansali and Disha Singhvi as Whole-time Directors, Nagendraa Parakh as Independent Director and Chairman.
• · Registered office to shift to Lower Parel, Mumbai.
• · 53rd AGM scheduled for September 18, 2026 via VC/OAVM.

11-08-2026

PB Fintech reported robust Q1 FY27 results, with consolidated operating revenue up 40% YoY to ₹1,888 Cr and PAT surging 92% YoY to ₹163 Cr, driving PAT margin improvement from 6% to 9%. Insurance premium grew 41% YoY to ₹8,372 Cr, led by a 53% rise in new health and term insurance (health alone up 59% YoY). While growth momentum is strong across insurance, credit, and UAE operations, management flagged that future profitability may remain tempered as they intentionally prioritize reinvestment in growth over near-term margin expansion.

• · 82% of insurance customers are first-time buyers (no prior policy).
• · Over 30% of health insurance business is sold on monthly mode to improve affordability.
• · Top 100 PB Partners account for only 16% of PB Partners premium, showing a relatively diversified base.
• · Employee benefit expenses rose to 15% of revenue in Q1 FY27 from 12% in the prior quarter (seasonal effect).
• · Credit business returned to growth with core disbursals up 33% YoY.
• · UAE insurance premium grew 31% YoY despite a challenging macro environment.
• · The company earned a 5-year revenue CAGR of 51% from Q1FY22 to Q1FY27.
• · Management indicated a cautious stance on near-term margin expansion, prioritizing growth reinvestment (e.g., acquisition spends).
• · Potential regulatory changes in commission structures (effort-based) were discussed; management mentioned possibility of PB Fintech becoming an insurance manufacturer in a worst-case scenario.

11-08-2026

GSP Crop Science Ltd reported Q1 FY27 (quarter ended June 30, 2026) standalone revenue of ₹4,242.05 million, up 6.0% YoY from ₹4,002.42 million, while net profit rose 28.4% YoY to ₹312.82 million from ₹243.54 million. However, revenue declined 1.2% sequentially from ₹4,293.25 million in Q4 FY26. The board approved the appointment of a new independent director, accepted the resignation of another, and confirmed full utilisation of IPO proceeds with no deviation.

• · IPO of 75,00,000 fresh equity shares and 50,00,000 OFS shares listed on NSE and BSE on March 24, 2026.
• · Net IPO proceeds of ₹1,130.53 million fully utilised as of June 30, 2026; ₹595.58 million for debt repayment and ₹534.95 million for general corporate purposes.
• · 41st AGM scheduled for September 18, 2026 via video conferencing; record date for dividend is September 11, 2026.
• · Appointment of Chirag Shah & Associates as Secretarial Auditor for 5 years from FY 2026-27 to FY 2030-31.
• · Mr. Nakul Jayesh Sharedalal resigned as Independent Director effective August 11, 2026, citing other professional commitments.
• · Alteration of Object Clause of MOA proposed, subject to shareholder approval.
• · Limited review report contains no qualifications.

11-08-2026

Kamat Hotels (India) Limited reported consolidated Q1 FY27 operational revenue of ₹905 Mn, up 10% YoY from ₹826 Mn, and EBITDA of ₹246 Mn, up 36% YoY, with EBITDA margin expanding 530 bps to 27%. PAT surged 126% YoY to ₹97 Mn (PAT margin 11% vs 5%). However, ARR declined across key brands: Orchid ARR fell 5% to ₹6,020, and IRA by Orchid ARR dropped 25% to ₹4,058, partly due to new property ramp-up. Occupancy improved to 66% from 55% YoY, but IRA by Orchid occupancy fell 16% to 62%.

• · Debt reduced substantially from ₹1,998 Mn in FY24 to ₹383 Mn net debt (adjusted for cash) as of Q1 FY27.
• · Net worth stood at ₹3,326 Mn as of FY26, up from ₹2,785 Mn in FY25.
• · Cash flow from operations for FY26 was ₹977 Mn, compared to ₹720 Mn in FY25.
• · Same-store revenue (excluding IRA Mumbai closure and four new hotels) grew 17% YoY; same-store EBITDA grew 21% YoY.
• · Excluding IRA by Orchid Mumbai, IRA by Orchid portfolio ARR was flat YoY and RevPAR increased 3%.
• · Diluted EPS for Q1 FY27 was ₹3.19, up 125% from ₹1.42 in Q1 FY26.
• · The company has 7 upcoming properties with a total of 621 keys, expected to open between November 2026 and December 2029.
• · Revenue mix by hotels: Orchid 60%, IRA by Orchid 26%, Lotus Resorts 5%, Heritage Hotels 4% (as of FY26).
• · Revenue mix by category: Room Revenue 64%, Food & Beverage 40% (as of FY26).
• · Brand loyalty: 61% of sales come from repeat customers.
• · The Orchid brand has won over 95 national and international awards.

11-08-2026

Innova Captab Limited reported a strong start to FY27 with revenue from operations growing 34% YoY to ₹470.9 crore in Q1 FY27, driven by robust performance across both CDMO Services & Products (₹328.7 crore, +32% YoY) and Branded Generics (₹142.2 crore, +39% YoY). EBITDA grew 33% YoY to ₹75.1 crore, while EBITDA margin remained nearly flat at 16.0% versus 16.1% in Q1 FY26. PAT rose 42% YoY to ₹44.1 crore, with PAT margin improving to 9.4% from 8.8%. The company's Jammu facility is ramping up steadily, but overall capacity utilization remains sub-optimal, with the facility expected to reach optimum utilization in 5-6 years.

• · CDMO Services & Products contributed approximately 70% of total revenue in Q1 FY27.
• · The Jammu facility was commercialized in January 2025 and is eligible for a ₹480+ crore GST-linked incentive totaling 300% of investment in eligible plant and machinery, plus a capital interest subvention of 6% per annum on loans against eligible capex for 10 years.
• · The Jammu facility has 4 independent blocks and is expected to reach optimum utilization in 5-6 years.
• · The Baddi and Dehradun & Taloja plants are operating at 70-80% utilization, while the Jammu facility is still in ramp-up phase (FY26 un-utilized capacity 40-50% for some blocks).
• · The company has 9 manufacturing blocks across Baddi (3), Dehradun (1), Taloja (1), and Jammu (4).
• · EPS for Q1 FY27 was ₹7.71 vs ₹5.42 in Q1 FY26.
• · FY26 full-year revenue was ₹1,630 Cr, EBITDA ₹250 Cr (15.4% margin), PAT ₹141 Cr (8.6% margin).
• · Fixed assets grew from ₹150 Cr in FY23 to ₹780 Cr in FY26 (~5x).
• · The company received UK-MHRA GMP compliance certification for its Cephalosporin Baddi facility and PIC/S (SMDC, Ukraine) GMP compliance for the Kathua, Jammu facility in 2026.

11-08-2026

SEPC Limited reported consolidated total income from operations of ₹28,247.96 lakh for Q1 FY27 (June 30, 2026), up 38.6% YoY from ₹20,379.45 lakh in Q1 FY26. However, the company posted a net loss after tax of ₹1,105.09 lakh compared to a profit of ₹1,654.72 lakh in the same quarter last year, driven by a deferred tax charge of ₹2,421.99 lakh. The auditor's review report includes a qualified opinion on the carrying value of deferred tax assets (₹25,765.77 lakh) and overdue contract assets/trade receivables, indicating ongoing recoverability concerns.

• · The auditor's review report is qualified on two matters: (1) Deferred tax asset of ₹9,163.42 lakh recognized on carried forward losses may not be recoverable; (2) Overdue non-current contract assets (₹9,037.98 lakh) and trade receivables (₹5,844.92 lakh) are subject to recoverability uncertainty due to stalled projects and disputes.
• · Equity share capital increased 10.1% YoY to ₹1,94,332.28 lakh, reflecting a capital infusion or conversion during the year.
• · Standalone total income from operations grew 58.3% YoY to ₹12,752.36 lakh, but standalone net loss after tax widened to ₹1,816.60 lakh from a profit of ₹685.99 lakh.
• · Consolidated basic and diluted EPS turned negative at (₹0.06) for Q1 FY27 versus ₹0.11 in Q1 FY26.
• · The board meeting commenced at 3:30 PM and concluded at 6:45 PM on August 11, 2026.

11-08-2026

Delta Corp Limited reported standalone Q1 FY27 revenue of ₹133.43 Crore, up 1.9% YoY from ₹130.90 Crore, but net loss of ₹109.27 Crore versus a profit of ₹25.84 Crore in Q1 FY26, driven by a ₹200.62 Crore exceptional provision for GST liabilities following the Supreme Court judgment. The Board fixed August 17, 2026 as record date for a final dividend of ₹0.50 per share (subject to AGM approval) and scheduled the 35th AGM for September 10, 2026. While casino gaming revenue declined 1.7% YoY, hospitality revenue grew 37.9% YoY.

• · Record date for final dividend: 17 August 2026
• · AGM scheduled for 10 September 2026 via VC/OAVM
• · Board meeting held on 11 August 2026 from 4:00 PM to 7:15 PM
• · Company has investments of ₹650.58 Crore in two subsidiaries that received GST notices aggregating ₹5,457.29 Crore
• · Company provided short-term loans of ₹204.50 Crore to two subsidiaries as at 30 June 2026
• · No impairment required on investments and loans based on management assessment
• · Company believes it has strong grounds to contest mixed supply allegations; no provision recognized for that matter
• · Company will no longer be required to indemnify buyer (Head Digital Works) towards GST liability on DGL sale
• · Total comprehensive loss for Q1 FY27 was ₹94.49 Crore
• · Other equity (excluding revaluation reserve) stood at ₹2,186.15 Crore as of 31 March 2026

11-08-2026

AYM Syntex reported consolidated revenue from operations of ₹35,103 Lakh for Q1 FY27, up 7.5% YoY from ₹32,648 Lakh in Q1 FY26. Profit after tax surged to ₹866 Lakh from a loss of ₹356 Lakh in the same quarter last year, driven by improved margins and a one-time deferred tax credit of ₹227.50 Lakh. However, sequentially, revenue declined 4.0% from ₹36,577 Lakh in Q4 FY26, and EPS (basic) fell to ₹1.48 from ₹1.54 in the prior quarter.

• · The company exercised the option under section 200 of the Income Tax Act, 2025 to compute income tax at 25.17% effective from FY27, making tax expense not comparable with prior periods.
• · A one-time deferred tax credit of ₹227.50 Lakh was recognised in Q1 FY27 due to the tax rate change.
• · The merger of Mandawewala Enterprises Limited with AYM Syntex is pending NCLT hearing on August 27, 2026; shareholder and unsecured creditor meetings were held on May 25, 2026.
• · The wholly owned subsidiary AYM Textiles Private Limited contributed nil revenue and a net loss of ₹0.06 Lakh for the quarter.
• · Paid-up equity share capital increased to ₹5,873 Lakh from ₹5,861 Lakh due to ESOP allotment.

11-08-2026

Fortis Healthcare reported a steady Q1 FY27 with consolidated revenue of INR 2,545 crore, up 17.5% YoY, driven by hospital revenue growth of 19% to INR 2,187 crore and diagnostic revenue growth of 10.2% to INR 407 crore. However, consolidated operating EBITDA margin (pre-ESOP) slipped slightly to 22.3% from 22.6% a year ago, and hospital EBITDA margin declined to 21.5% from 22.1%, though diagnostic margins improved to 23.9% from 23.0%. Net debt increased to INR 2,233 crore from INR 1,869 crore due to prior acquisitions, and the company maintained its FY28 margin guidance of 25% (pre-ESOP).

• · Hospital occupancy remained flat at 69% YoY.
• · Net debt-to-EBITDA ratio increased to 1.01x from 0.92x a year ago.
• · ESOP charge will be higher initially and then gradually decline over the next 3 years.
• · Management maintained FY28 margin guidance of 25% (pre-ESOP).
• · 14 facilities contributed 70% of hospital revenues and had EBITDA margins above 20%.
• · Agilus processed 10.5 million tests during the quarter.
• · B2C:B2B revenue mix improved to 53:47 from 51:49.
• · Preventive portfolio contribution increased to 14% from 12%; specialized portfolio to 35% from 34%.
• · Over 1,000 whole exome sequencing tests completed on NovaSeq X platform.
• · Board approved installation of a proton facility at Gurgaon flagship hospital.

11-08-2026

PI Industries reported a challenging Q1 FY27 with consolidated revenue declining 10% YoY to ₹17,023 Mn, EBITDA falling 29% to ₹3,693 Mn, and PAT dropping 39% to ₹2,442 Mn. The Agchem Exports segment saw a ~12% decline (volume down 8%) due to soft global demand, while PIHS revenue contracted 25% YoY due to order book phasing. However, the Domestic business showed revival with volume up ~12% (revenue grew ~3%), and the Biologicals segment grew aggressively at 50%+ YoY. The company remains net debt-free with surplus cash of ₹37,939 Mn, enabling future strategic investments.

• · Standalone Q1FY27 performance was stronger: Revenue +10% YoY, EBITDA +20% YoY, PAT +26% YoY.
• · Net Working Capital reduced by 19 days to 120 days in Jun-26 from 139 days in Jun-25.
• · Total capex for Q1FY27 stood at INR 2,685 Mn, reflecting continued investment in manufacturing and R&D.
• · PIHS PBT loss widened to INR 617 Mn in Q1FY27 from INR 582 Mn in Q1FY26, a 6% increase in loss.
• · PIHS signed up as an exclusive partner for Integrated Drug Discovery with a Biotech company.
• · PIHS obtained QC Lab GMP Certification at Lodi site and renewed AIFA GMP Certification for Lodi site.
• · Biologicals: 2nd generation product Harpin αβ commercialized in 25+ countries; nematicide peptide product performing at par with leading chemical nematicides.
• · Newly registered PHC949 being tested in the US.
• · Debt/Equity ratio remained low at 0.02 as of Jun-26.
• · Delayed and uneven monsoon impacted Kharif sowing in the domestic market.

11-08-2026

Mufin Green Finance Limited reported a strong Q1 FY27 with Profit Before Tax surging 345.6% YoY to ₹18.82 Cr and Net Interest Income rising 64.3% YoY to ₹35.16 Cr. Total AUM grew 69.4% YoY to ₹1,599.23 Cr, driven by Mediclaim Financing disbursements which grew 56.2% YoY to ₹247.08 Cr. However, provisions and write-offs increased sharply by 167.6% YoY to ₹2.89 Cr, and the Gross NPA stood at 1.91%, while the Salary Saathi vertical's mature Rajasthan market saw a slight QoQ decline of 4.6% in disbursements.

• · Cumulative disbursements reached ₹2,217 Cr in Q1 FY27, while headcount fell 26.45% to 367 from 499 in Q1 FY26, demonstrating strong operating leverage.
• · Cost of borrowings declined to 11.17% in Q1 FY27 from 12.97% in Q2 FY26.
• · CRISIL assigned an LGD of 1% + 0.25% on the Mediclaim Premium Financing Pool in Q1 FY27.
• · New lender facilities of ₹125.00 Cr were added in June 2026 from Union Bank (₹25.00 Cr Term Loan) and Wint Wealth (₹100.00 Cr NCD facility).
• · The company has 6+ state government MoUs in progress for Salary Saathi expansion, compared to 2 live states currently.
• · B2C Climate Financing AUM stood at ₹140.34 Cr and B2B at ₹270.49 Cr in Q1 FY27.
• · The average ticket size for Mediclaim Financing is ₹55,000, for Salary Saathi is ₹2,88,000, and for MSME loans ranges from ₹60,000 to ₹25,00,00,000.

11-08-2026

Suven Life Sciences Limited has submitted the Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its Preferential Issue of convertible warrants amounting to ₹85,764.02 lakhs. As of June 30, 2026, the company has utilized ₹40,950.29 lakhs (47.7%) of the total proceeds, with ₹44,813.73 lakhs remaining unutilized. The funds are being deployed towards clinical development through its overseas subsidiary, drug discovery R&D, a new R&D centre, and general corporate purposes, with no deviations or material adverse events reported.

• · The issue period was June 21, 2025 to June 30, 2025.
• · The monitoring agency is CRISIL Ratings Limited.
• · No deviation from the objects of the issue was reported.
• · No material deviation from earlier monitoring agency reports was observed.
• · All government/statutory approvals related to the objects have been obtained.
• · The company has invested unutilized proceeds in debt mutual funds and fixed deposits with SBI, earning returns ranging from 5.30% to 8.20%.
• · As of June 30, 2026, the total market value of investments (including gains) was ₹46,828.97 lakhs.
• · The statutory auditor's certificate is dated July 21, 2026.

11-08-2026

KSH International Ltd submitted its Monitoring Agency Report for the quarter ended June 30, 2026, confirming no deviation from the objects of its IPO. However, there are delays in the utilization of funds for the rooftop solar power plant and general corporate purposes, which the company has addressed via board resolutions extending timelines. As of June 30, 2026, total unutilized IPO proceeds stood at Rs.52.10 crore, with Rs.45.00 crore deployed in fixed deposits.

• · IPO period: December 16-18, 2025; issue was undersubscribed.
• · Initial offer: 1,67,82,501 shares (fresh 1,09,37,500 + OFS 58,45,001); allotted 1,63,11,303 shares (fresh 1,09,37,500 + OFS 53,73,803).
• · Objects: Prepayment of borrowings (Rs.225.98 Cr), capex (Rs.87.02 Cr), rooftop solar (Rs.8.83 Cr), GCP (Rs.76.96 Cr), issue expenses (Rs.21.22 Cr).
• · As of June 30, 2026: Rs.367.90 Cr utilized out of Rs.420.00 Cr; Rs.52.10 Cr unutilized.
• · Unutilized proceeds deployed in fixed deposit with IndusInd Bank (Rs.45.00 Cr, maturing July 31, 2026, earning 5.90%) and bank balances.
• · Delay in rooftop solar plant and GCP; board extended timelines via resolutions dated May 14, 2026 and February 07, 2026 respectively.
• · No deviation from objects; no change in means of finance; no major deviation from prior monitoring report.

11-08-2026

String Metaverse Ltd's board approved unaudited consolidated results for Q1 FY27 (quarter ended June 30, 2026), showing strong revenue growth of 97.3% YoY to ₹39,240.35 lakh and net profit growth of 101.8% YoY to ₹3,692.38 lakh. However, the company's HFT segment posted a segment loss of ₹480.03 lakh, a sharp reversal from a profit of ₹159.42 lakh in the same quarter last year. The board also approved a proposal to raise up to ₹1,000 crore through various equity and debt instruments, subject to shareholder approval.

• · The company issued bonus shares in the ratio of 2:9 on June 22, 2026, and EPS has been restated accordingly.
• · The 32nd Annual General Meeting is scheduled for September 25, 2026 via video conferencing.
• · M/s. Balaramakrishna & Associates appointed as Scrutinizer for e-voting at the AGM.
• · The board meeting commenced at 11:30 AM IST and concluded at 12:35 PM IST.
• · The company has 4 Indian subsidiaries and 5 foreign subsidiaries.
• · Indian subsidiaries reported total revenues of Rs. Nil and total net loss after tax of Rs. 19.79 lakhs for the quarter.
• · Foreign subsidiaries reported total revenues of Rs. 39,240.35 lakhs and total net profit after tax of Rs. 3,592.53 lakhs for the quarter.

11-08-2026

Narendra Properties Ltd. reported a net profit of ₹88.48 Lakhs for Q1 FY27 (quarter ended June 30, 2026), a significant increase from ₹0.69 Lakhs in the preceding quarter (Q4 FY26) and up from ₹77.21 Lakhs in Q1 FY26. However, revenue from operations was nil for the quarter, a sharp decline from ₹275.20 Lakhs in Q1 FY26, with total income coming entirely from other income of ₹123.95 Lakhs. The Board also approved the re-appointment of directors, payment of consultancy fees to promoters, and the convening of the 31st Annual General Meeting.

• · The Board approved the re-appointment of Mr. Nishank Sakariya, who is liable to retire by rotation.
• · Payment of consultancy fees to promoters Mr. Narendra C Maher and Mr. Narendra Sakariya was approved.
• · Ms. Kavita Patel was re-appointed as an Independent Director for a second term from December 27, 2026, to December 26, 2031.
• · The Board authorized investments, loans, and guarantees up to ₹50 Crores under Section 186 of the Companies Act.
• · The 31st Annual General Meeting is scheduled for Tuesday, September 29, 2026.
• · M/s. Sneha Jain & Associates were appointed as Scrutinizers for electronic voting at the AGM.
• · The company has no separate reportable segments, operating primarily in construction and property development.

11-08-2026

Nicco Uco Alliance Credit Ltd has submitted its Annual Report for FY 2025-2026 to BSE and will hold its 42nd Annual General Meeting on 9th September 2026. Key AGM resolutions include the re-appointment of 73-year-old Managing Director & CEO Mr. Kaustubha Basu for three more years at a modest monthly salary of ₹40,000, the appointment of Mr. Abhijit Banerjee as an Independent Director, and a proposal to avail a loan of ₹12,00,000 from its subsidiary. No financial performance data is presented in this filing, and the report does not contain segment-level or period-over-period comparisons.

• · Annual Report FY 2025-2026 submitted under Regulation 34(1) of SEBI (LODR) Regulations, 2015.
• · 42nd AGM scheduled for Wednesday, 9th September 2026 at 11:00 AM at Registered Office, NICCO House, Kolkata.
• · Ordinary businesses include adoption of standalone and consolidated financial statements and re-appointment of Mrs. Anita Lahiri (retiring by rotation).
• · Special businesses include appointment of CS Rasna Goyal as Secretarial Auditor for five years (from FY 2026-2027), appointment of Mr. Abhijit Banerjee as Independent Director (special resolution), re-appointment of Mr. Kaustubha Basu as MD & CEO (special resolution), and availing a loan of ₹12,00,000 from subsidiary NIACL (special resolution).
• · Scrutinizer for remote e-voting: CS Rasna Goyal; voting platform: NSDL.
• · Proxy forms must be received by 11:00 AM on 7th September 2026.

11-08-2026

K.P. Energy Limited reported a stellar Q1 FY27, with consolidated total revenue surging 136% YoY to ₹52,097.25 Lakh (₹520.97 Cr) and PAT rising 2.6% to ₹2,607.80 Lakh (₹26.08 Cr). The Infrastructure Development segment revenue jumped 142% YoY, driving the overall top line to a record Q1 high, while the Sale of Power segment revenue grew 16% YoY. However, the Operation & Maintenance Services segment revenue declined 43% QoQ in the quarter, and consolidated EBITDA margin compressed to 11.9% from 22.6% a year ago due to a sharp rise in material costs.

• · Order book of ~2.16 GW across multi-year projects.
• · 48.5 MW of IPP already commissioned, with another 202 MW in pipeline.
• · Exploring offshore wind opportunities of 1–2 GW in Gujarat and Tamil Nadu via Balance of Plant (BOP).
• · First in India to install ‘Make in India’ 4.2M160 Wind Turbine with 160m rotor diameter and 140m hub height.
• · 24×7 Network Operations Centre uses SCADA and AI alerts for preventive maintenance.
• · No complaints received/pending during the quarter (standalone and consolidated).
• · Segment-wise: O&M Services Q1FY27 revenue declined 43% QoQ (₹293.79 Lakh vs ₹513.31 Lakh in Q4FY26).
• · Segment-wise: Infrastructure Development Q1FY27 segment profit (PBIT) declined 61% QoQ (₹4,725.06 Lakh vs ₹12,209.94 Lakh in Q4FY26).
• · Consolidated EBITDA margin fell to 11.9% in Q1FY27 from 22.6% in Q1FY26.

11-08-2026

Zydus Lifesciences reported Q1 FY27 revenue from operations of Rs. 80,170 mn, up 22% YoY, driven by strong growth in Consumer Wellness (+67%) and International Markets (+34%). However, EBITDA declined 8% YoY to Rs. 19,294 mn and Net Profit fell 36% YoY to Rs. 9,398 mn, impacted by higher R&D investments and acquisition-related costs. The company also completed the acquisition of Assertio Holdings and received priority review for Saroglitazar NDA.

• · R&D investments stood at Rs. 6,424 mn (8% of revenues).
• · Net Debt to Equity ratio was 0.22x and Net Debt to EBITDA was 0.70x as of June 30, 2026.
• · India Formulations business grew 20% YoY, outperforming IPM growth for the last 3 financial years.
• · North America Formulations filed 5 ANDAs, received approval for 9 ANDAs (including 4 tentative approvals), and launched 11 new products in the US during the quarter.
• · In Canada, received 2 ANDS approvals and launched 2 new products.
• · Consumer Wellness domestic business grew 5% YoY; skin & hair care grew 35% and food & nutrition grew 16% YoY, but seasonal brands de-grew due to softer summer season.
• · International Consumer Wellness business (including Comfort Click) grew 25% on a like-to-like basis.
• · Injectable manufacturing facility at Zydus Biotech Park received EIR with VAI classification after GMP surveillance inspection in April-May 2026.
• · USFDA granted priority review to NDA of Saroglitazar Magnesium for Primary Biliary Cholangitis.
• · Entered into a joint venture agreement with Sunshine Healthcare Lanka Limited to establish a pharmaceutical manufacturing facility in Sri Lanka.
• · Earnings call scheduled at 4:00 p.m. IST on August 11, 2026.

11-08-2026

Skipper Limited reported Q1 FY27 standalone revenue of ₹13,098.32 million, up 4.5% YoY from ₹12,538.62 million, and net profit of ₹564.73 million, up 26.5% YoY from ₹446.60 million. However, revenue declined 21.4% sequentially from ₹16,665.82 million in Q4 FY26, and the Infrastructure Projects segment, while growing 148% YoY, contributed only 19% of total revenue. The Board also approved the 45th AGM on September 15, 2026, with a record date of September 4, 2026.

• · Finance costs decreased 11.8% YoY to ₹466.94 million from ₹529.60 million.
• · Employee benefits expense increased 29.5% YoY to ₹714.16 million from ₹551.65 million.
• · Total segment assets stood at ₹44,400.07 million as of June 30, 2026, up 18.9% from ₹37,349.49 million a year ago.
• · Borrowings (term loan and working capital) increased to ₹10,834.90 million as of June 30, 2026, from ₹9,889.56 million a year ago.
• · The company allotted 92,23,402 equity shares on a preferential basis on July 31, 2026, at ₹470 per share, aggregating ₹4,335.00 million, and is awaiting listing approvals from NSE and BSE.
• · The 45th AGM will be held on September 15, 2026, via VC/OAVM, with record date for e-voting and dividend on September 4, 2026.

11-08-2026

Majestic Auto Ltd. reported unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended June 30, 2026). On a standalone basis, profit after tax rose sharply to ₹1,741.47 Lakh from ₹949.69 Lakh in the same quarter last year, driven by a surge in other income. However, revenue from operations declined to ₹347.44 Lakh compared to ₹2,028.57 Lakh a year earlier, and the sequential quarter (Q4 FY26) showed a net loss, indicating significant volatility.

• · Standalone other income for Q1 FY27 was ₹3,041.17 Lakh, up from ₹1,431.90 Lakh in Q1 FY26.
• · Standalone total expenses for Q1 FY27 were ₹495.77 Lakh, down from ₹789.44 Lakh in Q1 FY26.
• · Standalone EPS (basic) for Q1 FY27 was ₹16.75 versus a loss of ₹2.89 per share in Q4 FY26.
• · The Board approved a final dividend of ₹25 per equity share (250%) for FY2025-26, subject to shareholder approval, in addition to an interim dividend of ₹35 per share (350%), bringing total dividend for the year to ₹60 per share (600%).
• · The company's subsidiary Majestic IT Services Limited is included in the consolidated results.
• · The current quarter figures are not comparable with the prior year due to the sale of the subsidiary ETPL in September 2025, which contributed no revenue in the current quarter.

11-08-2026

Unichem Laboratories reported consolidated revenue of ₹632.62 Cr for Q1 FY27 (quarter ended June 30, 2026), up 20.1% YoY from ₹526.60 Cr in Q1 FY26 and up 10.0% sequentially from ₹575.12 Cr in Q4 FY26. Net profit swung to ₹41.47 Cr from a loss of ₹10.47 Cr in the same quarter last year, driven by revenue growth and lower expenses. However, other income declined sharply to ₹15.61 Cr from ₹23.47 Cr in the prior quarter, and the company continues to face headwinds from a European Commission fine settlement and labour code provisions.

• · The company has a single reportable segment: Pharmaceuticals.
• · Exceptional items in FY26 included a net gain of ₹201.86 Cr, primarily from disposal of land & building (₹275.52 Cr gain) offset by interest on European Commission fine (₹58.26 Cr) and past service cost under New Labour Codes (₹15.40 Cr).
• · The European Commission fine of Euro 19.55 million was fully settled on October 28, 2025; the fine principal (Euro 13.96 million) was provided in FY24, and interest was recorded in FY26.
• · The US and Niche subsidiaries contributed total revenues of ₹470.28 Cr and net profit of ₹12.39 Cr for Q1 FY27.
• · Other subsidiaries (South Africa, Brazil, China) contributed total revenues of ₹23.59 Cr and a net loss of ₹0.08 Cr for Q1 FY27.
• · The investment in associate is fully impaired and its financial information is not available for Q1 FY27.
• · The Board meeting was held on August 11, 2026, from 12:00 noon to 1:45 p.m.

11-08-2026

Solar Industries India Limited held its 31st Annual General Meeting on August 11, 2026, via video conference, with 65 shareholders present (3 promoters, 62 public). The Chairman highlighted growth in revenue, profitability, and EBITDA margins for FY2025-26, along with strategic initiatives and CSR commitments. All seven resolutions, including the final dividend of ₹11 per share and the re-appointment of a Whole-time Director, were proposed; e-voting results are to be disclosed within two working days.

• · The AGM was held via video conference with the deemed venue at the registered office in Nagpur.
• · The meeting commenced at 11:30 a.m. and concluded at 12:40 p.m., with 15 minutes allotted for e-voting.
• · Remote e-voting was open from August 8, 2026, 9:00 a.m. to August 10, 2026, 5:00 p.m.
• · The statutory auditor reports did not contain any qualifications, observations, or adverse remarks.
• · Resolutions included adoption of financial statements, dividend declaration, re-appointment of Milind Deshmukh, appointment of Reena Jha Tripathi as Independent Director, alteration of Articles of Association, and ratification of Cost Auditor's remuneration.
• · E-voting results to be submitted to stock exchanges and uploaded on the company's website within 2 working days from the AGM conclusion.

11-08-2026

Escorp Asset Management Limited reported unaudited financial results for the quarter ended June 30, 2026, showing a net profit of ₹408.91 Lakhs, a significant increase from ₹72.54 Lakhs in the same quarter last year. However, total income declined to ₹492.81 Lakhs from ₹92.14 Lakhs in Q2 FY25, while total expenses decreased sharply to ₹11.88 Lakhs from ₹5.47 Lakhs. The Board also approved the draft Board's report, notice of the 15th Annual General Meeting scheduled for September 10, 2026, and appointment of a scrutinizer.

• · The Board meeting commenced at 12:30 P.M. and concluded at 1:45 P.M. on August 11, 2026.
• · The 15th Annual General Meeting is scheduled for September 10, 2026, via Video Conferencing.
• · M/s. ING&CO.LLP (Firm Registration Number 1.2024MHO017500) appointed as Scrutinizer for the AGM.
• · The company has only one business segment: Financial Services and related activities.
• · Other Comprehensive Income for the quarter was ₹659.54 Lakhs (net of tax), compared to ₹68.43 Lakhs in the prior year quarter.
• · Total Comprehensive Income for the quarter was ₹1,068.44 Lakhs, versus ₹140.97 Lakhs in Q2 FY25.
• · Earnings per share (basic and diluted) for the quarter: ₹3.68, compared to ₹0.65 in the prior year quarter.
• · The auditor's review report states no material misstatement was found.